| 查看: 544 | 回复: 5 | |||
| 【有奖交流】积极回复本帖子，参与交流，就有机会分得作者 vnyh3993 的 46 个金币 ，回帖就立即获得 1 个金币，每人有 1 次机会 | |||
[交流]
IgY-Technology英文专著在Springer出版
|
|||
|
IgY-Technology: Production and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice 近日，IgY抗体技术专著（IgY-Technology: Production and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice, Springer Nature Group, Switzerland. 2021. ISBN: 978-3-030-72686-7. https://www.springer.com/gp/book/9783030726867#aboutBook）在Springer出版社出版，该书是全球范围内第一部针对IgY抗体技术的系统性英文学术专著，由张小莺教授领衔主编，联合近二十个国家的四十多位学者历时多年编撰而成。 专著链接：https://www.springer.com/gp/book/9783030726867#aboutBook 该专著共18章，系统性的回顾和总结了IgY抗体技术的发展历程、技术特点和发展前沿，涉及理论基础、技术方法学及生物医药领域的研发应用。专著覆盖了IgY技术相关的各个领域，如进化视野下的IgY分子机制、受体与转运机制、免疫技术、IgY抗体的不同提取纯化策略、储存稳定性、工业化生产、在人类和兽医领域中的应用、IgY递送策略、IgY基因工程抗体制备、转基因动物开发、IgY产品报批及产业化，技术局限与创新等。 近年来，IgY抗体技术（卵黄抗体技术）不断发展，具备了相对完备统一的技术模式；不断与现代生物学技术相结合，拓展技术自生的内涵和外延；相关产品在世界范围内不断报批问世，形成了一定的产业基础。 据悉，科学出版社将与张小莺教授团队合作，在2011年中文版的基础上，适时推出IgY抗体技术中文第二版，以供中国读者和研究人员参考、交流。 图书信息 This first edited Volume on IgY-Technology, addresses the historical and dynamic development of IgY-applications. The authors cover the biological basis and theoretical context, methodological guidance, and applications of IgY-Technology. A focus is laid on the use of IgY-antibodies for prophylactic/therapeutic purposes in human and veterinary medicine. Aside from applications, the chapters also offer an evolutionary understanding of the IgY molecule, IgY receptors and practical prerequisites to produce IgY-antibodies. Guidance is given for every step of the process. Starting with an introduction to hens as a model species and including hen husbandry, hen egg-laying capacity and total IgY outcomes. Readers will also learn about immunization techniques, the advantages and limitations of different IgY extraction methods, as well as storage stability of the final product. The last part of the volume highlights hands-on aspects of applications, such as IgY delivery strategies, new methods to produce monoclonal IgY-antibodies or production of functional IgY fragments by phage-display as well as commercial exploitation of the technology. Thus, this book is a valuable resource and guide for Scientists, Clinicians and Health Product Developers in both human and veterinary medicine. 主编信息 Prof. Dr. Xiaoying ZHANG, PhD in Pharmacology (Charité Medical University Berlin), Distinguished Professor at Shaanxi Univ. of Technology (2019-present); Senior Researcher at CBMA, Univ. of Minho, Portugal (2016-present); Professor (Adjunct) at Univ. of Guelph, Canada (2017-present); Professor at Northwest Agricultural & Forestry Univ., China (2008-2018). He has been dedicated to the development, popularisation and application of IgY Technology. Ricardo S. Vieira-Pires is an Assistant Investigator at the Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Portugal. He obtained his PhD in Structural Biology (2008) at University Joseph Fourier, Grenoble, France. He is head of the Structural Biotechnology Group that studies proteins and molecular assemblies involved in key processes of bacterial and viral infectious diseases. He is particularly interested in targeting microbial surface-exposed virulent factors using antibodies. He is head of the CNC – Avian Technological Unit that explores bird immune repertoires for antibody discovery. He is engaged with academic and industry partners promoting IgY Technology-based solutions for human and veterinary medicine. Patricia M. Morgan is an Emerita Senior Lecturer at the National University of Ireland Galway (NUI Galway). Having been awarded a PhD in Biochemistry at NUI Galway, she undertook post-doctoral research at the University of Wisconsin-Madison, USA in the areas of reproductive biology and endocrinology. She has held senior positions at NUI Galway as Dean of the College of Science and Dean of Graduate Studies. In these posts, she has championed research developments within the University particularly in the areas of Biotechnology and Innovation. She has served on various national committees promoting science and is an advocate for the public understanding of science and the promotion of inclusion and diversity in academia. Rüdiger Schade started his scientific career at the Institute of Pharmacology, Charité – Universitätsmedizin in Berlin, Germany, in 1976. Since the early 1990’s, his research has been strongly focused on the development, production and application of IgY antibodies. His contributions significantly influenced the field of IgY-technology and promoted the application of this technology worldwide, particularly in Latin-America. In acknowledgement of his research efforts, he received the FISEA prize – the International Foundation for the Substitution of Animal Experimentation, Luxemburg - in 1997. |
回复此楼» 猜你喜欢
想问一下有没有需要文章但是没时间带学生的研究生导师。
已经有19人回复
-
颜宁:基础研究应顶天立地,立地即从需求端作为问题的出发点,立项背景就是面向真实需求
已经有3人回复
-
发现督导在听课，需要跟TA招呼示意吗？有同学看手机、课件有疏漏算大问题吗？
已经有4人回复
-
催稿后秒拒
已经有6人回复
-
前同事拿我以前未中的国自然标书申请今年的国自然，现在基金委发来调查函
已经有10人回复
-
298求调剂
已经有9人回复
-
申请省自然科学基金，研究区能否是省外区域
已经有13人回复
-
国内科研环境差导致国内科研水平差的根源
已经有3人回复
-
CSC在职申请求问
已经有7人回复
-
家乡二本高校/沿海传统私企，如何抉择？
已经有15人回复
» 本主题相关商家推荐: (我也要在这里推广)
» 抢金币啦！回帖就可以得到:
-
海南大学物理与光电工程学院诚聘海内外优秀人才——海聚英才，共创未来
+1/193
-
厦门大学公共卫生学院全重室郑子峥课题组招收博士研究生（生物医药类）
+1/87
-
【专业EPR】：自由基(超氧、羟基、单线态氧)，空位缺陷；定量计算，VX: 761711562
+1/85
-
[佐治亚州立大学]-金志成课题组-凝聚体/酶动力学/造影剂–PhD/Post-doc招生-2024秋季
+1/83
-
深圳技术大学刘清侠院士团队与马来亚大学 招收钠离子电池方向联合培养博士生 研究助理
+1/39
-
材料专业招调剂生，可接收电子科学、电子信息、计算机，过六级
+1/36
-
瑞典-招聘一名二维材料压力传感器方向博后
+1/15
-
瓦赫宁根大学-嘉兴大学招收联合培养博士生2024秋季入学
+1/13
-
大佬们，聚合物核磁共振氢谱比chemdraw的氢谱预测少十多二十个是怎么回事
+1/11
-
求孟鲁司特中间体工艺
+1/7
-
愿每一个人都能被生活温柔以待
+1/6
-
关于访问学者是否需要国自然的问题？
+1/6
-
德国硕士生找博导
+1/6
-
重庆科技大学电子智能材料研究所招聘物理学类、材料类、电子信息类专业的博士（事业编
+1/6
-
【南华大学】目前有部分地质类研究生调剂名额。
+1/4
-
昆士兰大学 张西旺课题组 PhD招生
+1/2
-
中国科大苏州高等研究院张振教授/江雷院士2024级博士生招生
+1/2
-
知名外资仪器公司急招Regional Product Marketing Manager
+1/2
-
南京征女友
+1/2
-
北达科他州立大学 谷物科学 全奖博士 招生
+1/1
+1/193
简单回复
tzynew2楼
2021-03-15 23:23
回复
vnyh3993(金币+1): 谢谢参与
o 发自小木虫Android客户端
2021-03-15 23:46
回复
vnyh3993(金币+1): 谢谢参与
2021-03-17 09:14
回复
vnyh3993(金币+1): 谢谢参与
7
nono20095楼
2021-08-27 07:29
回复
vnyh3993(金币+1): 谢谢参与
·
nono20096楼
2021-08-27 07:29
回复
·
